BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21696046)

  • 21. Pretransplant malignancy in pediatrics is not a risk factor for renal graft failure.
    Mandel A; Robinson SG; Peticca B; Prudencio TM; Karhadkar SS
    Pediatr Transplant; 2024 Feb; 28(1):e14697. PubMed ID: 38317342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.
    Hussain SK; Makgoeng SB; Everly MJ; Goodman MT; Martínez-Maza O; Morton LM; Clarke CA; Lynch CF; Snyder J; Israni A; Kasiske BL; Engels EA
    Transplantation; 2016 Nov; 100(11):2453-2460. PubMed ID: 26636741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Risk of Failure With HLA Mismatch and Recipient Age in First Pediatric (<18 years) Kidney Transplants.
    Williams RC; West LJ; Opelz G
    Transplant Direct; 2018 Jul; 4(7):e365. PubMed ID: 30046655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIRCHE application major versions 3 and 4 lead to equivalent T cell epitope mismatch scores in solid organ and stem cell transplantation modules.
    Matern BM; Niemann M
    Hum Immunol; 2024 May; 85(3):110789. PubMed ID: 38521663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive Long-Term Outcome of Kidney Allocation via Acceptable Mismatch Program in Highly Sensitized Patients.
    Strehler Y; Lachmann N; Niemann M; Halleck F; Budde K; Pruß A
    Transfus Med Hemother; 2024 Jun; 51(3):140-151. PubMed ID: 38867807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic Benefits of 0-antigen Mismatched Transplants: No Added Boost for Racial and Ethnic Minorities.
    Caldwell JS; Parvathinathan G; Stedman MR; Ahearn P; Tan JC; Cheng XS
    Transplant Direct; 2024 Jul; 10(7):e1653. PubMed ID: 38881747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Challenge of Preoperative Panel Reactive Antibody Positivity in Parathyroid Transplantation.
    Goncu B; Yucesan E; Salepcioglu Kaya H; Kazancioglu R; Ersoy YE; Akcakaya A
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):233-242. PubMed ID: 38385404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision transplant pathology.
    Wood-Trageser MA; Xu Q; Zeevi A; Randhawa P; Lesniak D; Demetris AJ
    Curr Opin Organ Transplant; 2020 Aug; 25(4):412-419. PubMed ID: 32520786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Genetic HLA Matching on Liver Transplantation Outcome: A Systematic Review and Meta-Analysis.
    Kok G; Ilcken EF; Houwen RHJ; Lindemans CA; Nieuwenhuis EES; Spierings E; Fuchs SA
    Ann Surg Open; 2023 Sep; 4(3):e334. PubMed ID: 37746594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint testing of donor and recipient genetic matching scores and recipient genotype has robust power for finding genes associated with transplant outcomes.
    Arthur VL; Guan W; Loza BL; Keating B; Chen J
    Genet Epidemiol; 2020 Nov; 44(8):893-907. PubMed ID: 32783273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies.
    Randhawa PS; Starzl T; Ramos HC; Nalesnik MA; Demetris J
    Am J Kidney Dis; 1994 Jul; 24(1):72-7. PubMed ID: 8023827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-year survival following lung transplantation.
    Miggins JJ; Reul RM; Barrett S; Rana A; Alnajar A; Dunson J; Shafii A; Garcha P; Goss J; Loor G
    J Thorac Dis; 2023 Jun; 15(6):2997-3012. PubMed ID: 37426158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated local ellipsoid protrusion supplements HLA surface characterization.
    Niemann M; Matern BM; Spierings E
    HLA; 2024 Jan; 103(1):e15260. PubMed ID: 37853578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benchmark Outcomes in Deceased Donor Kidney Transplantation: A Multicenter Analysis of 80 996 Transplants From 126 Centers.
    Rompianesi G; Montalti R; Vrakas G; Zarrinpar A; Warren C; Loiaco G; Rubba F; Troisi RI
    Transplant Direct; 2024 May; 10(5):e1618. PubMed ID: 38606349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COST-EFFECTIVENESS OF HUMAN LEUKOCYTE ANTIGEN MATCHING IN PENETRATING KERATOPLASTY.
    Bäumler M; Sundmacher L; Reinhard T; Böhringer D
    Int J Technol Assess Health Care; 2014 Feb; ():1-9. PubMed ID: 24499612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between donor-recipient genetic distance and long-term kidney transplant outcome.
    Stapleton CP; Lord GM; ; Conlon PJ; Cavalleri GL
    HRB Open Res; 2020; 3():47. PubMed ID: 33655195
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term outcome after renal transplantation in childhood.
    Rees L
    Pediatr Nephrol; 2009 Mar; 24(3):475-84. PubMed ID: 17687572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the human leukocyte antigen's relatively homogeneous genetic background relate to better lung transplantation outcomes in Japan?
    Matsumoto K; Tomoshige K; Doi R; Nagayasu T
    J Thorac Dis; 2023 Nov; 15(11):6373-6378. PubMed ID: 38090302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Race, ethnicity, ancestry, and aspects that impact HLA data and matching for transplant.
    Madbouly A; Bolon YT
    Front Genet; 2024; 15():1375352. PubMed ID: 38560292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime Time for HLA Desensitization: Imlifidase in the Spotlight.
    Bestard O; Moreso F; Dorling A
    Transpl Int; 2023; 36():11616. PubMed ID: 37456683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.